Chemoinformaics analysis of (+)-PIPERITENONE-OXIDE
| Molecular Weight | 166.22 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 10 |
| Exact Molecular Weight | 166.099 | nRing | 2 |
| Solubility: LogS | -2.289 | nHRing | 1 |
| Solubility: LogP | 1.992 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 27.6391 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.406 |
| Synth | 4.169 |
| Natural Product Likeliness | 3.29 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.009 |
| HIA | 0.006 |
| CACO-2 | -4.567 |
| MDCK | 0.0000228 |
| BBB | 0.155 |
| PPB | 0.696204 |
| VDSS | 1.758 |
| FU | 0.395275 |
| CYP1A2-inh | 0.18 |
| CYP1A2-sub | 0.667 |
| CYP2c19-inh | 0.124 |
| CYP2c19-sub | 0.886 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.074 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.52 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.455 |
| CL | 10.678 |
| T12 | 0.705 |
| hERG | 0.01 |
| Ames | 0.52 |
| ROA | 0.825 |
| SkinSen | 0.455 |
| Carcinogencity | 0.489 |
| EI | 0.22 |
| Respiratory | 0.877 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.903992 |